kabutan

Chordia Therapeutics, The Current Fiscal Year's Net Income to Widen

Tue Oct 14, 2025 11:30 am JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE Growth] announced its financial results at noon (11:30) on October 14th. The net loss (non-consolidated) for the fiscal year ended August 2025 was loss of 1.78 billion yen, a reduction in the deficit compared to loss of 1.78 billion yen in the previous term. For the fiscal year ending August 2026, the net loss is expected to be loss of 1.96 billion yen. This will mark the third consecutive term of losses.

In the most recent three-month period, from June to August (4Q), the net loss improved to a deficit of 0.38 billion yen (compared to a loss of 0.65 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 0 -1,789 -1,769 -1,785 -26.0 0 Oct 14, 2025 J-GAAP
YoY +0.7% +3.0% +2.3% +16.3%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2025 Guidance -2,434 -2,378 -2,380 -34.5 0 Oct 11, 2024 J-GAAP
Aug, 2025 Results 0 -1,789 -1,769 -1,785 -26.0 0 Oct 14, 2025 J-GAAP
Revision Rate +26.5% +25.6% +25.0% +24.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2024 0 -996 -975 -976 -14.3 0 Apr 11, 2025 J-GAAP
Sep - Feb, 2025 Guidance 0 Oct 14, 2025 J-GAAP
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 0 -1,789 -1,769 -1,785 -26.0 0 Oct 14, 2025 J-GAAP
Aug, 2026 Guidance -2,008 -1,958 -1,960 -27.9 0 Oct 14, 2025 J-GAAP
YoY -12.2% -10.7% -9.8% -7.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jun - Aug, 2024 0 -621 -649 -650 -11.1 -Inf Oct 11, 2024 J-GAAP
Sep - Nov, 2024 0 -624 -615 -616 -9.1 -Inf Jan 14, 2025 J-GAAP
Dec - Feb, 2024 0 -372 -360 -360 -5.3 -Inf Apr 11, 2025 J-GAAP
Mar - May, 2025 0 -424 -422 -423 -6.2 -Inf Jul 14, 2025 J-GAAP
Jun - Aug, 2025 0 -369 -372 -386 -5.6 -Inf Oct 14, 2025 J-GAAP
YoY +40.6% +42.7% +40.6% +49.1%

Related Articles